pantoprazole has been researched along with Hypocalcemia in 3 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Hypocalcemia: Reduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, Chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed)
Excerpt | Relevance | Reference |
---|---|---|
"The study was designed to detect novel Adverse Events (AEs) of pantoprazole by disproportionality analysis in the FDA (Food and Drug Administration) database of Adverse Event Reporting System (FAERS) using Data Mining Algorithms (DMAs)." | 5.91 | Pantoprazole associated dyspepsia hypocalcemia and hyponatremia: A disproportionality analysis in FDA adverse event reporting system (FAERS) database. ( Eswaran, M; Kulkarni, AR; Nair, HP; Subeesh, V, 2023) |
"The study was designed to detect novel Adverse Events (AEs) of pantoprazole by disproportionality analysis in the FDA (Food and Drug Administration) database of Adverse Event Reporting System (FAERS) using Data Mining Algorithms (DMAs)." | 1.91 | Pantoprazole associated dyspepsia hypocalcemia and hyponatremia: A disproportionality analysis in FDA adverse event reporting system (FAERS) database. ( Eswaran, M; Kulkarni, AR; Nair, HP; Subeesh, V, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Nair, HP | 1 |
Kulkarni, AR | 1 |
Eswaran, M | 1 |
Subeesh, V | 1 |
Fatuzzo, P | 1 |
Portale, G | 1 |
Scollo, V | 1 |
Zanoli, L | 1 |
Granata, A | 1 |
Quasdorff, M | 1 |
Mertens, J | 1 |
Dinter, J | 1 |
Steffen, HM | 1 |
3 other studies available for pantoprazole and Hypocalcemia
Article | Year |
---|---|
Pantoprazole associated dyspepsia hypocalcemia and hyponatremia: A disproportionality analysis in FDA adverse event reporting system (FAERS) database.
Topics: Adverse Drug Reaction Reporting Systems; Drug-Related Side Effects and Adverse Reactions; Dyspepsia; | 2023 |
Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Biomarkers; Cerebellar Diseases; Dietary Supplements; | 2017 |
Recurrent hypomagnesemia with proton-pump inhibitor rechallenge.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Dyspepsia; Female; Humans; Hypocalcemia; Magnesium; | 2011 |